Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunhee Kim

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.
Cancer Research and Treatment|May 19, 2016
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant GliomaYongjun Cha, Yu Jung Kim, Se-Hoon Lee, et al.
Blood|December 3, 2021
Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndromeCourtnee A Clough, Joseph Pangallo, Martina Sarchi, et al.
JCI Insight|February 5, 2026
Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformationHyejin Park, Jung-Eun Park, Bridger H Freeman, et al.
Journal of Neuroinflammation|November 28, 2021
Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19Jude Savarraj, Eun S Park, Gabriela D Colpo, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECTYun Jung Bae, Jong-Min Kim, Eunhee Kim, et al.
Nature Communications|May 19, 2017
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemiaJean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, et al.
Blood|August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
Journal of the National Cancer Institute|April 5, 2017
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer RiskCelia Byrne, Giske Ursin, Christopher F Martin, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.
Cancer Research and Treatment|May 19, 2016
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant GliomaYongjun Cha, Yu Jung Kim, Se-Hoon Lee, et al.
Blood|December 3, 2021
Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndromeCourtnee A Clough, Joseph Pangallo, Martina Sarchi, et al.
JCI Insight|February 5, 2026
Endothelial oncogenic KRAS mutation drives the dynamics of microglia and macrophages in brain arteriovenous malformationHyejin Park, Jung-Eun Park, Bridger H Freeman, et al.
Journal of Neuroinflammation|November 28, 2021
Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19Jude Savarraj, Eun S Park, Gabriela D Colpo, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECTYun Jung Bae, Jong-Min Kim, Eunhee Kim, et al.
Nature Communications|May 19, 2017
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemiaJean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, et al.
Blood|August 15, 2019
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, et al.
Journal of the National Cancer Institute|April 5, 2017
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer RiskCelia Byrne, Giske Ursin, Christopher F Martin, et al.
Pageof 29